CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Immunicum AB

For profitWebsite ↗

Also known as: Immunicum AB

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jan 14, 2019

Acquired by DCPrime BV on Dec 21, 2020

Timeline

2000s

Jun 1, 2002
Immunicum AB— Founded

2020s

Dec 21, 2020
DCPrime BV— Acquired By

Drugs by trial phase (5 distinct, 5 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT03735290Lead sponsorPhase 1/Phase 2Jan 14, 2019
NCT03735290Study directorPhase 1/Phase 2Jan 14, 2019
NCT02686944Lead sponsorPhase 1Jun 1, 2016
NCT02686944Study directorPhase 1Jun 1, 2016
NCT02432846Lead sponsorPhase 2Apr 1, 2015
NCT01974661Lead sponsorPhase 1Oct 1, 2013
NCT01525017Lead sponsorPhase 1Feb 1, 2012

Details

Founded: Gothenburg, SE Jun 1, 2002
Last known activity: Jan 14, 2019